• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Basic Clin Physiol Pharmacol . COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young ma

tetano

Editor, Senior Moderator
J Basic Clin Physiol Pharmacol


. 2021 Oct 29.
doi: 10.1515/jbcpp-2021-0227. Online ahead of print.
COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males


Fabrizio I Scroppo[SUP] 1 [/SUP], Elisabetta Costantini[SUP] 2 [/SUP], Alessandro Zucchi[SUP] 3 [/SUP], Ester Illiano[SUP] 2 [/SUP], Francesco Trama[SUP] 2 [/SUP], Stefano Brancorsini[SUP] 4 [/SUP], Felice Crocetto[SUP] 5 [/SUP], Maria Rita Gismondo[SUP] 6 [/SUP], Federico Dehò[SUP] 1 [/SUP], Anna Mercuriali[SUP] 7 [/SUP], Riccardo Bartoletti[SUP] 3 [/SUP], Francesco Gaeta[SUP] 8 [/SUP]



Affiliations

Abstract

Objectives: We want to evaluate the possible presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in semen samples and semen quality, looking for a possible relationship between the infectious disease and fertility.
Methods: In this prospective study, we enrolled 15 consecutive men (age 18-50 years) with positive oropharyngeal swab to SARS-CoV-2 and classified, according to WHO criteria, in mild to moderate disease. A semen sample was collected to detect SARS-CoV viral RNA by the automated Real-Time PCR ELITe InGenius[SUP]®[/SUP] system and the GeneFinder[SUP]TM[/SUP] COVID-19 Plus RealAmp Kit assay (ELITechGroup, France). Analysis of semen characteristics was performed according to WHO laboratory manual 5th ed. for the examination and processing of human semen. Blood samples for the dosage of hormonal assay, procalcitonin, interleukin 6, C-reactive protein were obtained.
Results: SARS-CoV-2 RNA has not been detected in semen samples from any of the subjects analysed. Sperm analysis exhibited abnormal seminal values in 14 out of 15 patients (93.3%). Furthermore, no difference was detected regarding sperm quality between mild and moderate SARS-CoV-2 patients. No alteration in the inflammatory indices was observed in the studied population, as well gonadotropins and testosterone levels.
Conclusions: COVID patients studied exhibits alteration of the seminal fluid both in microscopic and macroscopic characteristics such as hypoposia and increased viscosity, which have not been detected in previous studies. The presence of viral RNA within the seminal fluid was excluded.

Keywords: COVID-19; SARS-CoV-2; liquid semen analysis; male genital tract; spermatogenesis.
 
Back
Top Bottom